Comparison of CIMT vs Mirror Therapy Effect in Infarcted CVA Patients for Improving Hand Functions
Launched by SUPERIOR UNIVERSITY · May 25, 2024
Trial Information
Current as of November 16, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different therapies—Constraint-Induced Movement Therapy (CIMT) and Mirror Therapy—to see which one helps improve hand function in patients who have had a stroke that caused damage to the brain (also known as an infarcted cerebral vascular accident or CVA). The study is currently active but not recruiting new participants. It will take place at several locations, including physiotherapy centers and hospitals.
To be eligible for this trial, patients must be recovering from a stroke and need help improving their hand function. They should be between 2 months to 1 year post-stroke and able to participate in 45-minute therapy sessions. However, those whose hand issues are caused by reasons other than the stroke, or who have specific shoulder problems, won't qualify. Participants can expect to engage in either CIMT or Mirror Therapy sessions, which may help them regain better control and movement in their hands.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infarcted CVA patients
- • Patients with hand improvement needed
- • Patients in recovery stage of stroke from 2 months to 1 year
- • Patients who can participate in 45 mins of session
- Exclusion Criteria:
- • Patients with hand function disturbed due to any other reason except infarcted CVA, - - - Patients with shoulder subluxation and upper limb contractures
About Superior University
Superior University is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the university fosters a collaborative environment that brings together multidisciplinary teams of researchers, clinicians, and students. Superior University is focused on exploring novel therapeutic approaches and improving patient outcomes, leveraging its state-of-the-art facilities and cutting-edge technology. The institution adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and impact of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported